APOLLO MEDICAL HOLDINGS INC (AMEH) Stock Fundamental Analysis
NASDAQ:AMEH - US03763A2078 - Common Stock
40.82 USD
-0.88 (-2.11%)
40.82 USD
0 (0%)
We assign a fundamental rating of 7 out of 10 to AMEH. AMEH was compared to 102 industry peers in the Health Care Providers & Services industry. AMEH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. AMEH is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make AMEH a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
AMEH had positive earnings in the past year.
In the past year AMEH had a positive cash flow from operations.
Each year in the past 5 years AMEH has been profitable.
Each year in the past 5 years AMEH had a positive operating cash flow.
1.2 Ratios
AMEH has a Return On Assets of 4.27%. This is in the better half of the industry: AMEH outperforms 74.58% of its industry peers.
With a decent Return On Equity value of 7.71%, AMEH is doing good in the industry, outperforming 71.19% of the companies in the same industry.
AMEH has a better Return On Invested Capital (7.06%) than 75.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMEH is in line with the industry average of 9.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROIC | 7.06% |
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
1.3 Margins
AMEH has a better Profit Margin (3.45%) than 75.42% of its industry peers.
In the last couple of years the Profit Margin of AMEH has grown nicely.
AMEH has a Operating Margin of 7.61%. This is in the better half of the industry: AMEH outperforms 77.97% of its industry peers.
In the last couple of years the Operating Margin of AMEH has grown nicely.
AMEH's Gross Margin of 16.34% is on the low side compared to the rest of the industry. AMEH is outperformed by 70.34% of its industry peers.
In the last couple of years the Gross Margin of AMEH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% |
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMEH is destroying value.
AMEH has more shares outstanding than it did 1 year ago.
The debt/assets ratio for AMEH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.53 indicates that AMEH is not in any danger for bankruptcy at the moment.
AMEH has a Altman-Z score of 4.53. This is amongst the best in the industry. AMEH outperforms 83.90% of its industry peers.
AMEH has a debt to FCF ratio of 1.89. This is a very positive value and a sign of high solvency as it would only need 1.89 years to pay back of all of its debts.
The Debt to FCF ratio of AMEH (1.89) is better than 85.59% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that AMEH is not too dependend on debt financing.
The Debt to Equity ratio of AMEH (0.35) is better than 65.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.89 | ||
| Altman-Z | 4.53 |
ROIC/WACC0.85
WACC8.27%
2.3 Liquidity
AMEH has a Current Ratio of 2.35. This indicates that AMEH is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.35, AMEH is doing good in the industry, outperforming 79.66% of the companies in the same industry.
A Quick Ratio of 2.35 indicates that AMEH has no problem at all paying its short term obligations.
AMEH has a Quick ratio of 2.35. This is amongst the best in the industry. AMEH outperforms 81.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 |
3. Growth
3.1 Past
The earnings per share for AMEH have decreased strongly by -29.58% in the last year.
AMEH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.03% yearly.
AMEH shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.05%.
AMEH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.94% yearly.
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
3.2 Future
Based on estimates for the next years, AMEH will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.59% on average per year.
Based on estimates for the next years, AMEH will show a very strong growth in Revenue. The Revenue will grow by 26.59% on average per year.
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 40.82, AMEH can be considered very expensive at the moment.
Based on the Price/Earnings ratio, AMEH is valued a bit cheaper than 60.17% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.03. AMEH is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 28.34, AMEH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMEH indicates a somewhat cheap valuation: AMEH is cheaper than 62.71% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, AMEH is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMEH is valued a bit cheaper than 61.86% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AMEH is valued a bit cheaper than 73.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.06 | ||
| EV/EBITDA | 15.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMEH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of AMEH may justify a higher PE ratio.
A more expensive valuation may be justified as AMEH's earnings are expected to grow with 15.59% in the coming years.
PEG (NY)2.64
PEG (5Y)N/A
EPS Next 2Y16.56%
EPS Next 3Y15.59%
5. Dividend
5.1 Amount
AMEH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
40.82
-0.88 (-2.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners53.14%
Inst Owner Change-1.36%
Ins Owners21.32%
Ins Owner Change0%
Market Cap1.90B
Analysts83.33
Price Target47.49 (16.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DP7.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.72%
Min EPS beat(2)9.8%
Max EPS beat(2)39.63%
EPS beat(4)3
Avg EPS beat(4)20.8%
Min EPS beat(4)-0.9%
Max EPS beat(4)39.63%
EPS beat(8)6
Avg EPS beat(8)22.78%
EPS beat(12)10
Avg EPS beat(12)32.72%
EPS beat(16)12
Avg EPS beat(16)-118.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)4.65%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)17.32%
Revenue beat(8)6
Avg Revenue beat(8)8.34%
Revenue beat(12)10
Avg Revenue beat(12)8.2%
Revenue beat(16)12
Avg Revenue beat(16)7.16%
PT rev (1m)4.22%
PT rev (3m)-6.25%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)7.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 | ||
| P/S | 1.43 | ||
| P/FCF | 17.06 | ||
| P/OCF | 14.21 | ||
| P/B | 3.2 | ||
| P/tB | 7.79 | ||
| EV/EBITDA | 15.55 |
EPS(TTM)1
EY2.45%
EPS(NY)1.44
Fwd EY3.53%
FCF(TTM)2.39
FCFY5.86%
OCF(TTM)2.87
OCFY7.04%
SpS28.49
BVpS12.74
TBVpS5.24
PEG (NY)2.64
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROCE | 11.61% | ||
| ROIC | 7.06% | ||
| ROICexc | 10.35% | ||
| ROICexgc | 25.21% | ||
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% | ||
| FCFM | 8.4% |
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
ROICexc(3y)12.15%
ROICexc(5y)11.69%
ROICexgc(3y)43.38%
ROICexgc(5y)51.37%
ROCE(3y)12.51%
ROCE(5y)12.79%
ROICexcg growth 3Y1.89%
ROICexcg growth 5YN/A
ROICexc growth 3Y32.67%
ROICexc growth 5YN/A
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
F-Score6
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.89 | ||
| Debt/EBITDA | 1.76 | ||
| Cap/Depr | 132.23% | ||
| Cap/Sales | 1.68% | ||
| Interest Coverage | 8.45 | ||
| Cash Conversion | 113.54% | ||
| Profit Quality | 243.47% | ||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 | ||
| Altman-Z | 4.53 |
F-Score6
WACC8.27%
ROIC/WACC0.85
Cap/Depr(3y)82.27%
Cap/Depr(5y)51.68%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.01%
Profit Quality(3y)102.9%
Profit Quality(5y)124.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
EBIT growth 1Y7.56%
EBIT growth 3Y44.74%
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y28.75%
EBIT Next 5YN/A
FCF growth 1Y77.28%
FCF growth 3Y67.35%
FCF growth 5YN/A
OCF growth 1Y67.48%
OCF growth 3Y81.79%
OCF growth 5YN/A